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1 Introduction
Metabolism is a dynamic process that involves transport of metabolites and thousands of chemi-
cal reactions in which thousands of compounds are converted into others. Alternative pathways
and branches are continuously activated or shut down to maximize metabolic efficiency in a
specific context [18]. Metabolism is so complex that the underlying processes can hardly be
understood without using simplified mathematical representations. The most comprehensive
formulations are genome-scale Reconstructions (GEMs). For homo sapiens there are several of
these reconstructions like Recon 1 and 2 [6,20] or the Edinburgh human metabolic network [11].
Alongside these reconstructions follows the development of extensive reaction databases, like
the HMR [1, 2] or HumanCyc [5, 17], which collect information to refine the available models.
EMs and models derived from GEMs following omics data integrations were successively used
to understand how perturbations in the metabolism lead to severe pathologies targets [2,7,12].
GEMs are generic representations of a cell of an organism comprising all the reactions that
can potentially get active regardless of the environment and cell type. Therefore they do not
cover the fact that the set of expressed genes and thereby the set of active reactions vary
significantly in function of the cellular context. This necessitates the generation of context-
specific models containing only pathways predicted to be active in a given environment. Most
context-specific reconstruction methods assume that the expression of genes correlates with
the active state of the related reactions. Although, this assumption is only partially justified,
context-specific models showed a higher predictive power than the GEMs from which they were
derived from [3, 9]. This is due to GEMs containing multiple alternative pathways that are
rarely simultaneously active and therefore tend to have an increased number of false negatives
in gene essentiality assays compared to context-specific models that only comprise the active
alternative pathway [4, 7, 8].
Recently we proposed an algorithm for the fast reconstruction of compact context-specific
metabolic networks (FASTCORE) that allowed dropping the reconstruction time of context-
specific networks to the time order of seconds [21]. This extremely low computational demand
opens new possibilities for improving the quality of the models. Several rounds of model re-
construction, testing of the models predictions against real experimental data, curation steps
of the input model and the set of core reactions as well as cross-validations assays are re-
quired to reconstruct high-quality models. These semi-automated model curations steps are in
such extend not possible with competing algorithms due to their high computational demands.
FASTCORE requires as input a GEM and a set of core reactions being active in the context
of interest. FASTCORE identifies a close to minimal set of non-core reactions from the input
model to be added to the core set in order to obtain a consistent model, in which every reaction
in the model is able to carry a non-zero flux. To reconstruct compact models, the inclusion of
non-core reactions is penalized [21].
But the question which genes are expressed in a given cell-type and therefore the establish-
ment of the core set of reactions is non-trivial. Microarray expression data, so far the most
popular data source for model contextualization, allow comparing the probe expression levels
between two conditions. But probe effects do not allow a direct comparison between the probe
sets, as the amount of noise is non-negligible and varies within probe sets so that higher in-
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tensity does not imply higher expression levels or even to state that a gene is expressed [23].
Further the intensities retrieved from microarray data are continuous while FASTCORE, like
most context-specific algorithm require a binary input data (the establishing core set).
To adapt FASTCORE for the integration of microarray data, we therefore propose a new
workflow: FASTCORMICS. FASTCORMICS requires as input microarray data and a GEM.
Like FASTCORE, FASTCORMICS is devoid of heuristic parameter settings and has a low com-
putational demand with overall building times in the order of a few minutes FASTCORMICS
preprocesses the microarrays data with the discretization tool Barcode [14, 23]. Barcode uses
prior knowledge on the intensity distribution of each probe set for a given microarray platform
to segregate between expressed genes and non-expressed genes. The preprocessing step with
Barcode allows circumventing the need of setting a heuristic expression threshold that segre-
gates between expressed and non-expressed genes as e.g. in [3,7,24]. Choosing such a threshold
is arbitrary and critical for the output metabolic models as in response to this threshold com-
plete branches, alternative pathways, or subsystems might be included or excluded, thereby
heavily changing the functionalities of the model. Further, Barcode shows a better correlation
between predicted expression and protein expression than competing discretization methods
for the segregation of gene expression and allows to reduce batch and lab-effects that affect
measurements [23].
FASTCORMICS was validated via an essentiality assay performed on two cancer models
(cancer1 and cancer2) extracted respectively from Recon 1 and Recon 2 by the FASTCORMICS
workflow. The predicted essential genes were compared to a list of essential genes established in
[10] in a shRNA knockdown screen on cancer cell lines. The predictive power of the reconstructed
context-specific models was compared to the original GEMs and to a generic cancer model [7]
built by the competing MBA algorithm [9]. Furthermore, as a second quality control step,
enrichment in neoplasia-related genes retrieved from the DisGeNET database in the predicted
essential genes was assessed with a hypergeometric test to check for the model ability to predict
cancer relevant genes. In general, FASTCORMICS outperforms competing algorithms and
allows obtaining high-quality, robust models in a high-throughput manner. This will allow the
use of metabolic modelling as routine process for the analysis of microarray data e.g. in the
field of personalized medicine.
2 Materials and methods
2.1 Workflow overview
The general workflow of FASTCORMICS (figure1) contains a discretization step with Barcode
to obtain a list of genes expressed in the context of interest. The latter is then mapped to the
consistent generic model via the model’s Gene-Protein-Reactions Rules (GPR) to obtain a list
of active reactions (core reactions). For reactions that are under the control of one gene, the
discretized gene expression value is directly mapped to the reaction; otherwise if more genes are
associated to a reaction, the relationship between the genes and the reaction is given by Boolean
Rules. A Boolean AND means that all the genes have to be expressed to activate the reaction,
which is typically the case when a reaction is controlled by a complex of proteins. Therefore the
minimum of the discretized values is mapped to the reaction. A Boolean OR signifies that only
one gene has to be expressed, the maximal value is mapped to the reaction. Boolean ANDs and
ORs can be combined inside a same rule i.e. ((A AND B) OR C), in this example the minimal
value D is computed between A and B then the maximum between D and C is matched to the
reaction. Reactions that are predicted active according to the GPR rules constitute the set of
core reactions that are fed into a modified version of FASTCORE (mFC) that allows leaving
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Figure 1. FASTCORMICS Workflow: After discretization of the microarray data with
Barcode, the expressed genes are mapped to the input model according to the
Gene-Protein-Reactions rules . The FASTCORE core set is composed of reactions under the
control of Barcode-supported genes. Optionally, the model can be constrained in function of
the medium composition and a biomass function. A modified version of FASTCORE, that
allows the definition of a set of non-penalized reactions (in this study: barcode-supported core
reactions) is run. The modified version of FASTCORE forces the biomass function to carry a
non-zero flux while penalizing the inclusion of non-core reactions. The output of the modified
FASTCORE is then added to the core set and the modified FASTCORE is run again, this
time, forcing all core reactions to carry a flux while penalizing non-core reactions. Transporters
are removed from the core set, but are not penalized as explained in the main text.
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a set of reactions not penalized besides defining core and non-core reactions. The inclusion
of the set of non-penalized reactions are, unlike core reactions, not forced but only preferred
over the inclusion of non-core reactions, which are penalized. Barcode-supported transporters,
are a good example for the need of this new reaction set. Transporter reactions are generally
under the control of promiscuous genes (in the consistent version of Recon 2 [20], e.g. the gene
SLC7A6 controls 294 reactions) and therefore transporters should be removed from the core set
as otherwise whole subsystems would be included in the output model due to one gene. Nev-
ertheless, the inclusion of barcode-supported genes should be preferred over non-core reaction
which are not supported and therefore barcode-supported transporters are not be penalized.
For more details on FASTCORE see the original paper [21]. A Matlab implementation of the
FASTCORE algorithm can be downloaded from bio.uni.lu/systems biology/software. Two op-
tional steps can be included in the workflow. The first one allows to constrain the model with
respect to the medium composition if this is information is available. The uptake reactions
for metabolites that are not present in the medium are shut down and FASTCC [21] is run to
remove reactions that cannot carry a flux due to these medium constraints. The second op-
tional step allows adding a biomass function to the model. FASTCORMICS forces the biomass
function to carry a flux while penalizing the inclusion of non-core reactions (Figure 1). Core
reactions, including core transporters are not penalized in order to find, within the different
alternatives sets of reactions that allows the production of biomass, the one that contain the
highest number of core reactions. The output reactions of the modified FASTCORE are then
added to the core set and the modified FASTCORE is run a second time to now force all the
core reactions to carry a flux while penalizing the non-core reactions. Transporter reactions are
removed from the core set but are not penalized during the reconstruction to favour barcode-
supported transporters over non-core reactions that are not supported. If no biomass function
was added, Fastcormics is only run ones.
2.2 Microarray preprocessing with Barcode of cancer cell line data
The NCI dataset composed of 174 Hgu133plus2 arrays corresponding to 59 cancer cell lines
was downloaded from the Cell miner web page [19] and read in version 2.15.1 of R with the
affy package (1.36.1). The arrays were normalized with the frozen Robust Multi-array Average
package (fRMA version 1.14.0) [13] and then processed with the Barcode [23] function using
the hgu133plus2frmavrecs vector (version 1.1.12) into a list of expressed genes and another list
of genes with intensity values not significantly different from the intensities obtained for same
probesets in an unexpressed state (Figure 1). The ubiquity of expression (number of arrays for
which a gene is expressed over the total number of arrays) was computed for each gene and a
list of genes Entrez IDs with their respective score was then loaded in Matlab (version 2013a)
and mapped via the Gene Protein Reactions Rules (GPR) to the consistent version of Recon1
(consistRecon1, 2469) and Recon2 (consistRecon2, 5317) obtained with FASTCC . Reactions
tagged as expressed in 90% of the 174 arrays were included in the core set with the exception of
Barcode-supported transport reactions (core transporters), as the genes controlling the latter
are in general promiscuous. The core transporters were excluded from the core set, but were
not penalized later during the building process.
2.3 Building of cancer models constraint to growth on RPMI medium
To simulate the growth of the cancer cells on RPMI medium, the uptake reactions of the
consistent versions of Recon 1 and Recon 2 were first constrained with respect to the medium
composition and a biomass function taken from [22] was added to the GEMs. FASTCC [21]
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was run to remove reactions that are not able to carry a flux due to these additional medium
constraints (Figure 1).
The modified FASTCORE was then run on the medium-constrained models forcing the
biomass function to carry a flux while penalizing the inclusion of non-core reactions. This step
allows selecting preferentially among all the alternative pathways for the production of biomass
the one with the lowest number of non-core reactions, not penalizing the inclusion of core
reactions. The reactions required to allow a biomass production were then added to the core
set and the modified FASTCORE was run again now forcing the inclusion of all core reaction
while penalizing the non-core reactions with the exception of core transporters (Figure 1).
2.4 Model validation based on a knock-out experiment to identify essential
genes
A knock-out experiment was performed on the obtained cancer models as described by [7]
applying Flux Balance Analysis (FBA) [15]. In [7], a gene is considered essential if its knock-
downs results in a decrease of the growth rate of more than 1%. To allow, a comparision
with [7], the 1% criteria was taken over, but the experiments were also repeated with a growth
rate dicrease criteria of 50% (growth -50%). The lists of essential genes were compared to the
ranked list of 8000 genes established by [10] based on a shRNA knockdown screen on cancer cell
lines. The rank of essential genes were compared to the rank remaining metabolic genes (set
of genes associated to Recon2 minus the essential genes) with a Kolmogorov-Smirnov test (KS-
test). In addition 1000000 random sets of genes of the same size were created and the respective
KS-test was computed for evaluating the likelihood to obtain the same or better KS-score by
chance. To further validate the predicted essential genes, a list of neoplasia-related genes was
retrieved from DisGeNET [16], a database for gene-disease associations. A hypergeometric test
was performed to evaluate the enrichment of neoplasia-related genes in the predicted essential
genes.
Results
Two generic cancer models were obtained via the integration of microarray data from the NCI
dataset [19] with the FASTCORMICS workflow. The first model (cancer1), derived from Recon
1, is composed of 816 reactions (Table 1) and is therefore bigger than the cancer model derived
in [7] (772 reactions). The second model (cancer2) was extracted from Recon 2 and is composed
of 1332 reactions. Essentiality assays performed on cancer1 and cancer2 predict 188 and 106
essential genes, respectively. The lists of essential genes were compared to a ranked list of
8000 genes established by [10] via a shRNA knock-outs assay. Metabolic genes are slightly
overrepresented in the top of the list (data not shown), suggesting that metabolic genes of
Recon 1 and Recon 2 are more essential than the remaining genes on the list. Furthermore, the
distribution of essential genes of the cancer models is different from the remaining metabolic
genes and shifted towards the top of the ranked list as showed by a one-side KS-test giving
p-values of 7.7232e-04 and 0.0095 for cancer1 and cancer2, respectively, compared to a p-value
of 0.0284 for the cancer model published in [7] that was built by the MBA algorithm [9].
A permutation test (Table 1) showed that the likelihood of finding a gene set of the same
size with a better KS-score by chance is low with a p-value of 1e-6 and 0.0022 for cancer1
and cancer2, respectively, against a p-value of 0.0044 for the cancer model built by the MBA
algorithm [7].
The Recon1 and Recon 2 models, further constrained by the medium composition, allowed to
only identify a smaller set of essential genes (Table 1) and their distribution were not significantly
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Table 1. Comparison of the essential genes found by the in silico essentiality assay to a
ranked gene list established by [10] defined as the effect of shRNA knock-downs on the
proliferation of cancer cells. In [7], a gene is considered essential if its knock-downs resulted in
a decrease of the growth rate of more than 1%. To allow, a comparision with [7], the 1%
criteria was taken over, but the experiments were also repeated with a growth rate decrease
criteria of 50% (growth -50%). *The number of essential genes was taken from supplementary
file msb201135-sup-0002.xls of [7]
output model generic model size essential genes p-value permutation p-value
cancer folger Recon1 772 178* 0.0284 0.0059
medium constrained
Recon 1 + biomass
Recon 1 1922 78 0.1908 0.1444
medium constrained
Recon 2 + biomass
Recon 2 4246 36 0.7777 0.7398
cancer1 Recon1 816 188 7.7232e-04 1e-06
cancer1 (growth -50 %) Recon1 816 92 0.0489 0.0324
cancer2 Recon2 1332 106 0.0095 0.0022
Table 2. Hypergeometric test quantifying the enrichment of neoplasia-related genes retrieved
from DisGeNet [16] in the set of essential genes , a database of disease-gene associations.
In [7], a gene is considered essential if its knock-downs resulted in a decrease of the growth
rate of more than 1%. To allow, a comparision with [7], the 1% criteria was taken over, but
the experiments were also repeated with a growth rate dicrease criteria of 50% (growth -50%).
output model essential genes
(EG)
EG in Dis-
GeNet
genes in the
generic models
(GG)
GG in Dis-
GeNet
p-value
cancer folger 178 84 1168 449 4.6 e-06
medium contrained Re-
con1 + biomass
78 33 1168 377 0.0350
medium constrained
Recon2 + biomass
36 14 1599 433 0.0806
cancer1 188 90 1168 377 8.1e-07
cancer1 (growth -50%) 92 39 1168 377 0.0063
cancer2 106 45 1599 433 2.9e-04
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different from the distribution of the metabolic genes for Recon1 and Recon 2 , confirming that
context-specific models perform better than the generic genome-wide reconstructions from which
they are extracted.
The hypergeometric test (Table 2) showed that the neoplasia-associated genes retrieved
from the DisGeNet database [16] are over-represented in the essential genes for all models This
confirms that the essential genes predicted by the cancer models are not false positives due to
model-specific bias like the lack of alternative pathways in the generic model or the removal of
the latter due to a high threshold
Discussion
We extended the FASTCORE algorithm [21], that allows reconstructing compact context-
specific metabolic models in the time order of seconds, towards the integration of microarray
data. The resulting FASTCORMICS workflow, that performs a reconstruction in the order
of a few minutes, was validated by an essentiality test performed on generic cancer models,
built by FASTCORMICS following the integration of an NCI microarray dataset. The essential
genes predicted by FASTCORMICS ranked highly in the list of essential genes establish by [10]
based on the shRNA knockdown effects on cancer cells proliferation and also were enriched for
neoplasia-related genes.
Unlike most competing algorithms, FASTCORMICS does not depend on the introduction
of heuristic thresholds for the segregation of expressed and non-expressed genes, which turns
the models built by FASTCORMICS more robust and less prompted to over-fitting of the data.
For the cancer model built by the competing MBA algorithm, considered as state of the art for
context-specific metabolic reconstructions, the threshold was set at an intensity value of 200 [7].
The size of the output model and therefore the number of essential genes is very sensitive to
the choice of this threshold. A higher threshold would have led to overestimation of essential
genes, due to a reduced number of alternative pathways included in the model, whereas a lower
threshold would have led to an underestimation of the number of essential genes. Moreover,
as the intensity distribution varies between experiments and platforms, the value of 200 that
seems adequate for this dataset, might be inadequate for another one. Further, when comparing
cancer1 with the cancer model built by MBA algorithm [9], cancer1 performed slightly better on
the essentiality test and the enrichment test. Finally, like for FASTCORE, core reactions fed to
MBA must have a high confidence level as all core reactions will be included in the output model.
Core reactions with low confidence level, due to a too low threshold or lab effects, can cause the
inclusion of a great number of non-core reactions into the output model in order to guarantee
a flux trough all core reactions. Barcode [23] used with the default setting (as performed here)
requires five standard deviation above its null mean to be regarded as expressed which drastically
limits the source of error in establishing the core reactions set. Other competing algorithms using
omics data for building of context-specific model like GIMME [3], IMAT [24] or, mCADRE [22],
INIT [1] or the MBA algorithm [9] have higher computational demands due to the used mixed
integer linear programming, and/or require setting of one expression, respectively two expression
thresholds for IMAT [24]. FASTCORMICS outperforms its competitors due to its robustness
and the low computational demand due to the efficient use of linear programming.
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